JL 13

Drug Profile

JL 13

Latest Information Update: 05 Jan 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Therabel
  • Class Antipsychotics; Dibenzazepines; Small molecules
  • Mechanism of Action Dopamine D4 receptor antagonists; Serotonin 2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Psychotic disorders

Most Recent Events

  • 05 Jan 2004 No development reported - Preclinical for Psychotic disorders in Belgium (unspecified route)
  • 05 Jul 2001 This compound is still in active development
  • 05 Jul 2001 A study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top